MedPath

Evaluation of Athiyadhi kashayam for its antidiabetic & antioxidant activities in Pilot study

Not Applicable
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2022/09/045502
Lead Sponsor
Meenakshi C
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients willing to sign informed consent form.

Patients willing to undergo routine blood investigation.

Exclusion Criteria

Patients with hypertension,

Diabetic complications - Diabetic neuropathy, Diabetic retinopathy, Diabetic nephropathy

Gestational diabetes,

Impaired glucose tolerance,

Patients of other mega noi types

Blood glucose value greater than 300 mg%

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The therapeutic efficacy of Athiyadhi Kashayam is assessed by comparing the reduction of blood glucose level before and after treatment in Madhumegam (Diabetes mellitus)Timepoint: 28 days
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath